Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastien A Burel

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 31, 2018
Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2'-MOE-Modified Antisense OligonucleotidePadmakumar Narayanan, Lijiang Shen, Brian R Curtis, et al.
Nucleic Acid Therapeutics|May 23, 2013
Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeysSebastien A Burel, So-Ri Han, Hong-Soo Lee, et al.
Nucleic Acid Therapeutics|February 12, 2020
Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated ThrombocytopeniaPadmaKumar Narayanan, Brian R Curtis, Lijiang Shen, et al.
Nucleic Acids Research|August 21, 2021
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A Anderson, Graeme C Freestone, Audrey Low, et al.
Nucleic Acids Research|November 11, 2015
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcriptsSebastien A Burel, Christopher E Hart, Patrick Cauntay, et al.
Journal of Medicinal Chemistry|February 26, 2016
Comprehensive Structure-Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to HepatocytesThazha P Prakash, Jinghua Yu, Michael T Migawa, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 31, 2018
Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2'-MOE-Modified Antisense OligonucleotidePadmakumar Narayanan, Lijiang Shen, Brian R Curtis, et al.
Nucleic Acid Therapeutics|May 23, 2013
Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeysSebastien A Burel, So-Ri Han, Hong-Soo Lee, et al.
Nucleic Acid Therapeutics|February 12, 2020
Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated ThrombocytopeniaPadmaKumar Narayanan, Brian R Curtis, Lijiang Shen, et al.
Nucleic Acids Research|August 21, 2021
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A Anderson, Graeme C Freestone, Audrey Low, et al.
Nucleic Acids Research|November 11, 2015
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcriptsSebastien A Burel, Christopher E Hart, Patrick Cauntay, et al.
Journal of Medicinal Chemistry|February 26, 2016
Comprehensive Structure-Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to HepatocytesThazha P Prakash, Jinghua Yu, Michael T Migawa, et al.
Pageof 2